Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | $971.4M | $615.5M | $2,898.1M | $4,072.1M | $6,348.4M | $3,480.5M | $5,670.1M | $5,541.6M | $4,260.6M | $4,641.7M | $2,801.2M | $1,146.6M | $3,759.0M | $3,452.0M | $2,506.3M | $3,483.1M | $4,470.5M | $5,387.5M | $4,600.4M | ($3,152.0M) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Eli Lilly and Company's last 12-month Free Cash Flow is ($2,178.8M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Eli Lilly and Company's Free Cash Flow growth was 1,221.3%. The average annual Free Cash Flow growth rates for Eli Lilly and Company have been N/A over the past three years, N/A over the past five years.
Over the last year, Eli Lilly and Company's Free Cash Flow growth was 1,221.3%, which is higher than industry growth of (0.2%). It indicates that Eli Lilly and Company's Free Cash Flow growth is Good.